270 related articles for article (PubMed ID: 28371475)
1. Impact of non-alcoholic fatty pancreas disease on glucose metabolism.
Yu TY; Wang CY
J Diabetes Investig; 2017 Nov; 8(6):735-747. PubMed ID: 28371475
[TBL] [Abstract][Full Text] [Related]
2. Non-Alcoholic Fatty Pancreas Disease (NAFPD): A Silent Spectator or the Fifth Component of Metabolic Syndrome? A Literature Review.
Romana BS; Chela H; Dailey FE; Nassir F; Tahan V
Endocr Metab Immune Disord Drug Targets; 2018; 18(6):547-554. PubMed ID: 29595117
[TBL] [Abstract][Full Text] [Related]
3. Nonalcoholic Fatty Pancreas Disease: Role in Metabolic Syndrome, "Prediabetes," Diabetes and Atherosclerosis.
Filippatos TD; Alexakis K; Mavrikaki V; Mikhailidis DP
Dig Dis Sci; 2022 Jan; 67(1):26-41. PubMed ID: 33469809
[TBL] [Abstract][Full Text] [Related]
4. Type 2 diabetes: Does pancreatic fat really matter?
Guglielmi V; Sbraccia P
Diabetes Metab Res Rev; 2018 Feb; 34(2):. PubMed ID: 28984071
[TBL] [Abstract][Full Text] [Related]
5. Non-alcoholic fatty pancreas disease - practices for clinicians.
Pinte L; Balaban DV; Băicuş C; Jinga M
Rom J Intern Med; 2019 Sep; 57(3):209-219. PubMed ID: 30901317
[TBL] [Abstract][Full Text] [Related]
6. Non-alcoholic fatty pancreas disease.
Alempijevic T; Dragasevic S; Zec S; Popovic D; Milosavljevic T
Postgrad Med J; 2017 Apr; 93(1098):226-230. PubMed ID: 28069746
[TBL] [Abstract][Full Text] [Related]
7. [Lipid accumulation in the pancreas: clinical significance of NAFPD (non-alcoholic fatty pancreas disease)].
Jermendy G
Orv Hetil; 2022 Oct; 163(44):1735-1742. PubMed ID: 36309887
[TBL] [Abstract][Full Text] [Related]
8. Nonalcoholic Fatty Pancreas Disease.
Shah N; Rocha JP; Bhutiani N; Endashaw O
Nutr Clin Pract; 2019 Oct; 34 Suppl 1():S49-S56. PubMed ID: 31535735
[TBL] [Abstract][Full Text] [Related]
9. ASSOCIATION BETWEEN NONALCOHOLIC FATTY PANCREATIC DISEASE AND TRIGLYCERIDE/GLUCOSE INDEX.
Andrade LJO; Oliveira LM; Bittencourt AMV; Baptista GM; Oliveira GCM
Arq Gastroenterol; 2023; 60(3):345-349. PubMed ID: 37792764
[TBL] [Abstract][Full Text] [Related]
10. Prevalence and factors associated with nonalcoholic fatty pancreas disease and its severity in China.
Weng S; Zhou J; Chen X; Sun Y; Mao Z; Chai K
Medicine (Baltimore); 2018 Jun; 97(26):e11293. PubMed ID: 29953011
[TBL] [Abstract][Full Text] [Related]
11. [NON-ALCOHOLIC FATTY PANCREATIC DISEASE (NAFPD) AND THE METABOLIC SYNDROME: INITIATING FACTOR OR ADDITIONAL COMPONENT?].
Grigorieva IN; Efimova OV; Tov NL; Suvorova TS
Eksp Klin Gastroenterol; 2015; (9):86-91. PubMed ID: 26931016
[TBL] [Abstract][Full Text] [Related]
12. Ectopic fat accumulation in the pancreas and its clinical relevance: A systematic review, meta-analysis, and meta-regression.
Singh RG; Yoon HD; Wu LM; Lu J; Plank LD; Petrov MS
Metabolism; 2017 Apr; 69():1-13. PubMed ID: 28285638
[TBL] [Abstract][Full Text] [Related]
13. Non-Alcoholic Fatty Pancreatic Disease: A Review of Literature.
Tariq H; Nayudu S; Akella S; Glandt M; Chilimuri S
Gastroenterology Res; 2016 Dec; 9(6):87-91. PubMed ID: 28058076
[TBL] [Abstract][Full Text] [Related]
14. Non-Alcoholic Fatty Pancreas Disease: The Unsung Disease.
Sevim BC; Chela H; Ertugrul H; Malik LS; Malik S; Basar O; Daglilar E; Samiullah S; Gaballah AH; Tahan V
Endocr Metab Immune Disord Drug Targets; 2023; 23(4):485-493. PubMed ID: 36177623
[TBL] [Abstract][Full Text] [Related]
15. Nonalcoholic Fatty Pancreas Disease: Clinical Consequences.
Dite P; Blaho M; Bojkova M; Jabandziev P; Kunovsky L
Dig Dis; 2020; 38(2):143-149. PubMed ID: 31865317
[TBL] [Abstract][Full Text] [Related]
16. Nonalcoholic fatty pancreas disease and Nonalcoholic fatty liver disease: more than ectopic fat.
Della Corte C; Mosca A; Majo F; Lucidi V; Panera N; Giglioni E; Monti L; Stronati L; Alisi A; Nobili V
Clin Endocrinol (Oxf); 2015 Nov; 83(5):656-62. PubMed ID: 26201937
[TBL] [Abstract][Full Text] [Related]
17. The association between pancreas steatosis and metabolic syndrome: A systematic review and meta-analysis.
Bi Y; Wang JL; Li ML; Zhou J; Sun XL
Diabetes Metab Res Rev; 2019 Jul; 35(5):e3142. PubMed ID: 30767421
[TBL] [Abstract][Full Text] [Related]
18. Protein kinase STK25 aggravates the severity of non-alcoholic fatty pancreas disease in mice.
Nuñez-Durán E; Chanclón B; Sütt S; Real J; Marschall HU; Wernstedt Asterholm I; Cansby E; Mahlapuu M
J Endocrinol; 2017 Jul; 234(1):15-27. PubMed ID: 28442507
[TBL] [Abstract][Full Text] [Related]
19. A Mouse Model of Metabolic Syndrome: Insulin Resistance, Fatty Liver and Non-Alcoholic Fatty Pancreas Disease (NAFPD) in C57BL/6 Mice Fed a High Fat Diet.
Fraulob JC; Ogg-Diamantino R; Fernandes-Santos C; Aguila MB; Mandarim-de-Lacerda CA
J Clin Biochem Nutr; 2010 May; 46(3):212-23. PubMed ID: 20490316
[TBL] [Abstract][Full Text] [Related]
20. Pathophysiological Mechanisms and Clinical Associations of Non-Alcoholic Fatty Pancreas Disease.
Pagkali A; Makris A; Brofidi K; Agouridis AP; Filippatos TD
Diabetes Metab Syndr Obes; 2024; 17():283-294. PubMed ID: 38283640
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
